MEDP Stock Overview
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Medpace Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$389.82 |
| 52 Week High | US$421.00 |
| 52 Week Low | US$197.39 |
| Beta | 1.4 |
| 1 Month Change | 3.60% |
| 3 Month Change | -0.98% |
| 1 Year Change | 92.37% |
| 3 Year Change | 134.99% |
| 5 Year Change | 596.48% |
| Change since IPO | 1,290.23% |
Recent News & Updates
Recent updates
A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
May 22
Does Medpace Holdings (NASDAQ:MEDP) Deserve A Spot On Your Watchlist?
Apr 12Medpace: Exceptional Performance, Almost Fully Priced In
Mar 11Medpace Holdings, Inc.'s (NASDAQ:MEDP) 32% Jump Shows Its Popularity With Investors
Feb 18Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?
Feb 09A Look At The Intrinsic Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
Jan 25Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?
Jan 10Shareholders Should Be Pleased With Medpace Holdings, Inc.'s (NASDAQ:MEDP) Price
Dec 26Should You Investigate Medpace Holdings, Inc. (NASDAQ:MEDP) At US$275?
Nov 08Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 29% Below Their Intrinsic Value Estimate
Oct 23If EPS Growth Is Important To You, Medpace Holdings (NASDAQ:MEDP) Presents An Opportunity
Oct 10Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?
Aug 27Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?
Jul 31A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
Jul 18Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today
Jul 04Is Medpace Holdings (NASDAQ:MEDP) A Risky Investment?
May 25Is Now The Time To Look At Buying Medpace Holdings, Inc. (NASDAQ:MEDP)?
Apr 27An Intrinsic Calculation For Medpace Holdings, Inc. (NASDAQ:MEDP) Suggests It's 28% Undervalued
Apr 12We Ran A Stock Scan For Earnings Growth And Medpace Holdings (NASDAQ:MEDP) Passed With Ease
Mar 27Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?
Feb 14What Is Medpace Holdings, Inc.'s (NASDAQ:MEDP) Share Price Doing?
Jan 16Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 41% Below Their Intrinsic Value Estimate
Jan 03Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today
Dec 20Medpace Holdings (NASDAQ:MEDP) Has A Rock Solid Balance Sheet
Nov 16Growth Investors: Industry Analysts Just Upgraded Their Medpace Holdings, Inc. (NASDAQ:MEDP) Revenue Forecasts By 13%
Nov 03Why Medpace Holdings, Inc. (NASDAQ:MEDP) Could Be Worth Watching
Oct 10Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 33% Below Their Intrinsic Value Estimate
Sep 26Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?
Aug 28We Think Medpace Holdings (NASDAQ:MEDP) Can Manage Its Debt With Ease
Aug 01Medpace 2022 revenue guidance above consensus estimate as Q2 beats on top, bottom lines
Jul 25Is Medpace Holdings, Inc. (NASDAQ:MEDP) Potentially Undervalued?
Jun 30Is Medpace Holdings, Inc. (NASDAQ:MEDP) Trading At A 47% Discount?
Jun 15Here's Why I Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today
May 13Shareholder Returns
| MEDP | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -4.0% | -0.1% | 1.2% |
| 1Y | 92.4% | 8.0% | 27.7% |
Return vs Industry: MEDP exceeded the US Life Sciences industry which returned 8% over the past year.
Return vs Market: MEDP exceeded the US Market which returned 27.7% over the past year.
Price Volatility
| MEDP volatility | |
|---|---|
| MEDP Average Weekly Movement | 4.4% |
| Life Sciences Industry Average Movement | 6.8% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: MEDP has not had significant price volatility in the past 3 months.
Volatility Over Time: MEDP's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 5,800 | August Troendle | www.medpace.com |
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services.
Medpace Holdings, Inc. Fundamentals Summary
| MEDP fundamental statistics | |
|---|---|
| Market cap | US$12.26b |
| Earnings (TTM) | US$312.32m |
| Revenue (TTM) | US$1.96b |
38.6x
P/E Ratio6.1x
P/S RatioIs MEDP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDP income statement (TTM) | |
|---|---|
| Revenue | US$1.96b |
| Cost of Revenue | US$658.67m |
| Gross Profit | US$1.30b |
| Other Expenses | US$991.82m |
| Earnings | US$312.32m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 10.10 |
| Gross Margin | 66.44% |
| Net Profit Margin | 15.91% |
| Debt/Equity Ratio | 0% |
How did MEDP perform over the long term?
See historical performance and comparison